Zogenix has completed its rolling submission of a New Drug Application in the US and submitted a marketing application in Europe for Fintepla for the treatment of seizures associated with Dravet syndrome. More: Zogenix submits new drug application to FDA
read moreRoche has announced that it has joined the World Federation of Hemophilia (WFH) Humanitarian Aid Program, a landmark initiative leading the effort to change the lack of access to care and treatment for people with inherited bleeding disorders in developing
read moreActivist hedge fund Starboard Value is “certainly interested in the story at Bristol-Myers,” according to its leader. But that doesn’t mean it’s getting involved. More: Bristol-Myers' rumored activists 'haven't made a decision' on the company yet: Starboard CEO Source: fierce
read moreGlaxoSmithKline had several years to prepare for the U.S. generic assault on its respiratory blockbuster Advair, offering discounts and rolling out new therapies to stay in the game. And now that the day has finally come, while sales are expected
read moreA jury ordered Takeda, which just scooped up Shire, to pay $155 million for patent infringement on a hemophilia drug sold by archrival Bayer. More: Takeda ordered to pay Bayer 5M for hemophilia patent infringement Source: fierce
read moreCancer drug Lartruvo’s shocking clinical trial failure, coupled with disappointing sales of drugs like Verzenio, prompted a cut into the higher-than-expected 2019 projections Lilly rolled out in December. And that put executives on the spot Wednesday as analysts pressed for
read more© 1994 - 2026 B.M. Pharmaceuticals